期刊文献+

高敏C反应蛋白与心房顿抑关系的临床研究 被引量:2

The clinical study of relation between high sensitivity C-reactive protein and atrial stunning
下载PDF
导出
摘要 目的探讨高敏C反应蛋白(hsCRP)与心房顿抑的关系。方法将冠脉造影排除冠心病的患者分为慢性房颤组68例和窦律组103例。将房颤患者进行复律。比较房颤组复律前与窦律组、以及复律前后血浆hsCRP水平。结果房颤组患者复律前较窦律患者hsCRP升高,分别为(6.3±1.2)mg/L和(2.3±0.4)mg/L;复律后hsCRP为(13.6±3.7)mg/L,较复律前升高。结论慢性房颤患者hsCRP升高,且hsCRP与心房顿抑相关,是心房顿抑的独立预测因子。 Objective To investigate the relation between hsCRP and atrial stunning. Methods The 171 cases who didn't be diagnosed as coronary heart disease by coronary angiography were divided into atrial fibrillation group(n=68)and sinus rhythm group ( n=103 ). The atrial fibrillation patients were cardioversed. The plasma hsCRP of the sinus rhythm patients, the atrial fibrillation patients before cardioversion and the ones after cardioversion were compared. Results After cardioversion, the plasma hsCRP increased frome (6.3±1.2)mg/L to (13.6±3.7)mg/L. The plasma hsCRP in the patients before cardioversion were higher than sinus rhythm patients [(2.3±0.4)mg/L]. Conclusion The plasma hsCRP in the chronic atrial fibrillation patients increases. The plasma hsCRP level is related to atrial stunning and is the independent predictors of atrial stunning.
出处 《中国心血管病研究》 CAS 2008年第8期589-591,共3页 Chinese Journal of Cardiovascular Research
关键词 高敏C反应蛋白 心房颤动 栓塞 心房顿抑 gh sensitivity C-reactive protein Atrial fibrillation Embolism Atrial stunning
  • 相关文献

参考文献8

  • 1[3]Sanders P,Morton JB,Kistter PM,et al.Reversal of artrial mechanical dysfunction after cardioversion of artrial fibrillation.Circulation,2003,108:1976-1984.
  • 2[4]Seidl K,Rameken M,Drogemulhr A,et al.Embolic events in patients with atrial fibrillation and effective anticoagulation:value of transesophageal echocardiography to guide direct-current cardioversion.J Am Coll Cardiol,2002,39:1436-1442.
  • 3[5]Khan IA.Atrial stunning:determinants and cellular mechanisms.Am Heart J,2003,145:787-794.
  • 4[6]Guijarro C.High sensitivity C-reactive protein:potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.Circulation,2001,104:E127.
  • 5潘伟,韩玉龙,方长庚,张小勇,刘学路,马敏,章体玲.他汀类药物对急性冠状动脉综合征患者血清妊娠相关性血浆蛋白-A的影响[J].中国医药,2007,2(9):524-526. 被引量:1
  • 6[8]Li JJ,Fang CH.C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular disease.Med Hypotheses,2004,62:499-506.
  • 7[9]Montero I,Orbe J,Varo N,et al.C-reactive protein induces matrix metalloproteinase-1 and-10 in human endothelial cells:implications for clinical and subclinical atherosclerosis.J Am Coll Cardiol,2006,47:1369-1378.
  • 8[10]Gedikli O,Dogan A,Altuntas I,et al.Inflammatory makers according to types of artrial fibrillation.Int J Cardiol,2007,120:193-197.

二级参考文献6

  • 1Khosravi J,Diamandi A,Krishna RG,et al.Pregnancy associated plasma protein-A:ultrasensitive immunoassay and determination in coronary heart disease[].Journal of Clinical Microbiology.2002
  • 2Boldt HB,Overgaard MT,Lauresen LS,et al.Mutational analysis of the proteolytic domain of PAPP-A:Classification as a metzincin[].Biochemical Journal.2001
  • 3Overgaard MT,Boldt HB,Laursen LS,et al.Pregnancy-associated plasma protein-A2 (PAPP-A2),a novel insulin-like growth factor- binding protein-5 proteinase[].Biological Chemistry.2001
  • 4Lund J,Qin QP,Ilva T,et al.Circulatin gpregnancy-associated plasma protein-A??predicts outcome in patients with acute coronary syndrome but no troponin Ⅰ elevation[].Circulation.2003
  • 5Qin QP,,Laitinen P,,Eriksson S, et al.Release patterns of pregnancy associated protein A in patients with acute coronary syndromes[].Scandinavian Cardiovascular Journal.2002
  • 6Alberto Dominguez-Rodriguez Pedro Abreu-Gonzalez Mart&#xed,n Garcia-Gonzalez Julio Ferrer and Manuel Vargas.Circulating pregnancy-associated plasma protein A is not an early marker of acute myocardial infarction[].Clinical Biochemistry.2005

同被引文献78

  • 1潘伟,方长庚,刘志平,杨瑞丰,光雪峰.阻塞性睡眠呼吸暂停综合征与急性冠状动脉综合征及冠状动脉病变关系的初步探讨[J].中国介入心脏病学杂志,2007,15(1):25-25. 被引量:3
  • 2Davi G, Tuttolomondo A, Santilli F, ct al. CD40 ligand and MCP - 1 as predictors of cardiovascular events in diabetic patients with stroke [ J ]. J Atherosclcr Thromb, 2009, 16 (6): 707-713.
  • 3Dominguez - Rodriguez A, Abreu - Gonzalez P, Garcia -Gonzalez M J, et al. Soluble CD40 ligand: interleu- kin - 10 ratio predicts in - hospital adverse events in pa- tients with ST - segment elevation myocardial infarction [J]. Thromb Res, 2007, 121 (3) : 293 -299.
  • 4Antoniades C, Bakogiannis C, Tousoulis D, et al. The CD40/CD40 ligand system: linking inflammation with atherothrombosis [J]. J Am Coll Cardiol, 2009, 54 (8): 669-677.
  • 5Unek IT, Bayraktar F, Solmaz D, et al. Enhanced levels of soluble CD40 ligand and C - reactive protein in a total of 312 patients with metabolic syndrome [ J ]. Metabolism, 2010, 59 (3): 305-313.
  • 6Reinboldt S, Wenzel F, Rauch BH, et al. Prelimina- evidence for a matrix metalloproteinase -2 (MMP - 2 ) - dependent shedding of soluble CD40 ligand (sCD40L) from activated platelets [ J ]. Platelets, 2009, 20 (6): 441 -444.
  • 7Enomoto Y, Adachi S, Matsushima - Nishiwaki R, et al. Thromboxane A (2) promotes soluble CD40 ligand release from human platelets [ J ]. Atherosclerosis, 2010, 209 (2): 415-421.
  • 8Cholette JM, Blumberg N, Pbipps RP, et al. Developmental changes in soluble CD40 ligand [ J]. J Pediatr, 2008, 152 (1): 50-54.
  • 9Guldiken S, Dernir M, Arikan E, et al, The levels of circulating markers of atheroselerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high - sensitivity C - reactive protein [J]. Thromb Res, 2007, 119 ( 1 ) : 79 - 84.
  • 10Rondina MT, Lappe JM, Carlquist JF, et al. Soluble CD40O ligand as a predictor of coronary artery disease and long- term clinical outcomes in stable patients undergoing coronary angiography [J]. Cardiology, 2008, 109 (3): 196 -201.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部